相关实验视频

Updated: May 28, 2025

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies

Published on: May 22, 2020

[与人类多克隆性免疫球蛋白的输液相关反应:来自法国国家药监数据库的分析]

Aurélie Bobet¹, Justine Bravo¹, Eyrian Aubin-Beale²

¹Département de pharmacologie médicale et clinique, centre de pharmacovigilance et de pharmacoépidémiologie, faculté de médecine, hôpital universitaire de Toulouse, 31000 Toulouse, France.

Therapie

|February 9, 2025

概括

与输液相关的免疫球蛋白反应通常以类似流感的症状出现. 管理涉及调整输液速率或停止治疗,可能使用修改后的方案重新注射.

科学领域:

免疫学免疫学免疫学
药物监督药物监督药物监督
临床药房临床药房

背景情况:

输液相关反应 (IRR) 是免疫球蛋白 (Ig) 治疗的已知并发症.
现实世界的数据对于理解这些反应的临床特征和管理至关重要.

研究的目的:

使用现实世界的数据来描述与输液相关的免疫球蛋白反应.
提供临床相关的有关IRRs的管理和复发的信息.

主要方法:

一项描述性研究分析了法国国家药监数据库中报告的239个IRR病例.
数据包括通过静脉注射 (IV) 或皮下 (SC) 途径给药的免疫球蛋白,直到2023年12月.

主要成果:

大多数IRR (97.4%) 与IV免疫球蛋白有关,通常呈现为类似流感的综合征 (51%).
反应通常发生在早期治疗周期 (1st为IV,第四为SC).
治疗包括输液中止 (87.7%) 或减速 (9.1%);在60%的病例中,重新注射是可行的,相同配方的复发率为40%,不同配方的复发率为75%.

结论:

与输液相关的免疫球蛋白反应经常表现为类似流感的综合征或心血管问题.
管理策略,如降低输液速率或前期治疗,有助于恢复治疗.
在相同的注射途径内切换免疫球蛋白配方似乎没有在预防复发方面提供显著的优势.

关键词:

不良反应不良反应抗体是对抗体的一种.抗体是一种抗体.临床实践中的临床实践不良影响不良影响.免疫球蛋白在静脉内使用.静脉内注射的免疫球蛋白是什么药物监督药物监督药物监督临床实践 (Pratique clinique) 是一种临床实践.

更多相关视频

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety

Published on: September 15, 2023

A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection

A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection

Published on: June 15, 2018

相关概念视频

Allergic Drug Reactions

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...

Pharmacovigilance

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...

Cross-reactivity

Cross-reactivity

Allergic Reactions

Allergic Reactions